Financials data is unavailable for this security.
View more
Year on year Bicycle Therapeutics PLC had net income fall 60.28% from a loss of 112.72m to a larger loss of 180.66m despite a 86.52% increase in revenues from 14.46m to 26.98m.
Gross margin | -- |
---|---|
Net profit margin | -417.88% |
Operating margin | -463.42% |
Return on assets | -21.88% |
---|---|
Return on equity | -30.24% |
Return on investment | -24.15% |
More ▼
Cash flow in USDView more
In 2023, Bicycle Therapeutics PLC increased its cash reserves by 55.38%, or 187.82m. Cash Flow from Financing totalled 250.03m or 926.85% of revenues. In addition the company used 60.63m for operations while cash used for investing totalled 2.93m.
Cash flow per share | -3.59 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 12.67 |
---|---|
Tangible book value per share | 12.67 |
More ▼
Balance sheet in USDView more
Current ratio | 14.77 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0354 |
---|---|
Total debt/total capital | 0.0342 |
More ▼